Literature DB >> 25939418

Clinical trials: A transparent future for clinical trial reporting.

Fotini B Karassa1, John P A Ioannidis2.   

Abstract

Mesh：

Year:  2015        PMID： 25939418     DOI： 10.1038/nrrheum.2015.65

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov.

Authors:  Michael R Law; Yuko Kawasumi; Steven G Morgan
Journal:  Health Aff (Millwood)       Date:  2011-12       Impact factor: 6.301

2.  The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence.

Authors:  John P A Ioannidis; Fotini B Karassa
Journal:  BMJ       Date:  2010-09-13

3.  Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.

Authors:  Nasim A Khan; Juan I Lombeida; Manisha Singh; Horace J Spencer; Karina D Torralba
Journal:  Arthritis Rheum       Date:  2012-07

Review 4.  Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

Authors:  John P A Ioannidis; Fotini B Karassa; Eric Druyts; Kristian Thorlund; Edward J Mills
Journal:  Nat Rev Rheumatol       Date:  2013-09-03       Impact factor: 20.543

5.  Clinical trial data sharing: what do we do now?

Authors:  Steven N Goodman
Journal:  Ann Intern Med       Date:  2015-02-17       Impact factor: 25.391

Review 6.  Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.

Authors:  Maria Elena Flacco; Lamberto Manzoli; Stefania Boccia; Lorenzo Capasso; Katina Aleksovska; Annalisa Rosso; Giacomo Scaioli; Corrado De Vito; Roberta Siliquini; Paolo Villari; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2015-02-07       Impact factor: 6.437

7.  Compliance with results reporting at ClinicalTrials.gov.

Authors:  Monique L Anderson; Karen Chiswell; Eric D Peterson; Asba Tasneem; James Topping; Robert M Califf
Journal:  N Engl J Med       Date:  2015-03-12       Impact factor: 91.245

8.  Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.

Authors:  Andrew P Prayle; Matthew N Hurley; Alan R Smyth
Journal:  BMJ       Date:  2012-01-03

9.  How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database.

Authors:  Hiroki Saito; Christopher J Gill
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240
  9 in total
  1 in total

1.  Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.

Authors:  Isaretta L Riley; L Ebony Boulware; Jie-Lena Sun; Karen Chiswell; Loretta G Que; Monica Kraft; Jamie L Todd; Scott M Palmer; Monique L Anderson
Journal:  Clin Trials       Date:  2017-11-10       Impact factor: 2.486
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.